We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stride's (LRN) Unit MedCerts Collaborates With Mason Center
Read MoreHide Full Article
Stride, Inc.’s (LRN - Free Report) subsidiary company MedCerts entered into a partnership with Mason Center for the expansion of the healthcare education program in Tennessee.
This collaboration will help the Tennessee community to have access to Mason Center’s state and nationally-recognized certification programs and training, get real-world clinical experience, connect with potential employers and receive financial assistance for qualified candidates. This will eventually help to meet the demand for healthcare positions in the state and prepare the future workforce.
MedCerts believes that this partnership will allow it to offer life-changing learning programs and career opportunities to a vast pool of interested candidates in the healthcare field. It is a top player in online healthcare that has developed more than 50 immersive online national certification training programs with best-in-class outcomes.
Stride’s Emphasis on Career Learnings
Shares of Stride have risen 31.2% in the year-to-date period compared with the Zacks Schools industry’s growth of 1.2%.
Image Source: Zacks Investment Research
Stride is witnessing consistent strength in its Career Learnings segment thanks to its growth strategy. In third-quarter fiscal 2023, total enrollment in this segment grew 60% from the prior-year quarter to 67,200 students. Also, enrollment in the General Education segment witnessed sequential growth of 3.1% to 114,600 students in the reported quarter, backed by the sustained demand for virtual options in the K-12 space.
In fiscal third-quarter 2023, total revenues of Stride were $470.3 million compared with $421.7 million in the year-ago period, courtesy of continued enrollment strength, increase in revenue per enrollment and Adult Learning growth. Considering the growth momentum, the company increased its fiscal 2023 revenue guidance to the range of $1.805 billion-$1.825 billion, up from the previous guidance of $1.775 billion to $1.815 billion.
Royal Caribbean Cruises presently sports a Zacks Rank #1. RCL has a trailing four-quarter earnings surprise of 26.4%, on average. The stock has surged 89.2% in the year-to-date period.
The Zacks Consensus Estimate for RCL’s 2023 sales and earnings per share (EPS) indicates a rise of 48.5% and 162.8%, respectively, from the year-ago period’s levels.
Skechers currently sports a Zacks Rank #1. SKX delivered a trailing four-quarter earnings surprise of 18.8%, on average. Shares of the company have increased 25.8% in the year-to-date period.
The Zacks Consensus Estimate for SKX’s 2023 sales and earnings per share (EPS) indicates a rise of 7.8% and 31.9%, respectively, from the year-ago period’s levels.
Crocs currently carries a Zacks Rank #2 (Buy). CROX has a trailing four-quarter earnings surprise of 19.6%, on average. Shares of the company have increased 6.6% in the year-to-date period.
The Zacks Consensus Estimate for CROX’s 2023 sales and EPS indicates a rise of 13.2% and 5.7%, respectively, from the year-ago period’s levels.
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Shutterstock
Stride's (LRN) Unit MedCerts Collaborates With Mason Center
Stride, Inc.’s (LRN - Free Report) subsidiary company MedCerts entered into a partnership with Mason Center for the expansion of the healthcare education program in Tennessee.
This collaboration will help the Tennessee community to have access to Mason Center’s state and nationally-recognized certification programs and training, get real-world clinical experience, connect with potential employers and receive financial assistance for qualified candidates. This will eventually help to meet the demand for healthcare positions in the state and prepare the future workforce.
MedCerts believes that this partnership will allow it to offer life-changing learning programs and career opportunities to a vast pool of interested candidates in the healthcare field. It is a top player in online healthcare that has developed more than 50 immersive online national certification training programs with best-in-class outcomes.
Stride’s Emphasis on Career Learnings
Shares of Stride have risen 31.2% in the year-to-date period compared with the Zacks Schools industry’s growth of 1.2%.
Image Source: Zacks Investment Research
Stride is witnessing consistent strength in its Career Learnings segment thanks to its growth strategy. In third-quarter fiscal 2023, total enrollment in this segment grew 60% from the prior-year quarter to 67,200 students. Also, enrollment in the General Education segment witnessed sequential growth of 3.1% to 114,600 students in the reported quarter, backed by the sustained demand for virtual options in the K-12 space.
In fiscal third-quarter 2023, total revenues of Stride were $470.3 million compared with $421.7 million in the year-ago period, courtesy of continued enrollment strength, increase in revenue per enrollment and Adult Learning growth. Considering the growth momentum, the company increased its fiscal 2023 revenue guidance to the range of $1.805 billion-$1.825 billion, up from the previous guidance of $1.775 billion to $1.815 billion.
Zacks Rank & Other Key Picks
Stride currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Some other top-ranked stocks from the Zacks Consumer Discretionary sector include Royal Caribbean Cruises Ltd. (RCL - Free Report) , Skechers U.S.A., Inc. (SKX - Free Report) and Crocs, Inc. (CROX - Free Report) .
Royal Caribbean Cruises presently sports a Zacks Rank #1. RCL has a trailing four-quarter earnings surprise of 26.4%, on average. The stock has surged 89.2% in the year-to-date period.
The Zacks Consensus Estimate for RCL’s 2023 sales and earnings per share (EPS) indicates a rise of 48.5% and 162.8%, respectively, from the year-ago period’s levels.
Skechers currently sports a Zacks Rank #1. SKX delivered a trailing four-quarter earnings surprise of 18.8%, on average. Shares of the company have increased 25.8% in the year-to-date period.
The Zacks Consensus Estimate for SKX’s 2023 sales and earnings per share (EPS) indicates a rise of 7.8% and 31.9%, respectively, from the year-ago period’s levels.
Crocs currently carries a Zacks Rank #2 (Buy). CROX has a trailing four-quarter earnings surprise of 19.6%, on average. Shares of the company have increased 6.6% in the year-to-date period.
The Zacks Consensus Estimate for CROX’s 2023 sales and EPS indicates a rise of 13.2% and 5.7%, respectively, from the year-ago period’s levels.